top of page
AEnB2Uq_HIiXrr6Uye1O7aZ5edPEz3r8ICmVEm8k9WIpa8GnDYiuQwMuSahKqwy82Yi7yRhU9ZSJdY5rzHIdRqOnNl
ABOUT CRINETICS

Crinetics Pharmaceuticals focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. All of our drug candidates are new chemical entities resulting from in-house drug discovery.

We take a patient-focused approach to our work, which means our scientists begin the drug discovery process by talking to patients and their healthcare providers. Our goal is to understand what the needs are and how our work can achieve more effective disease control while helping improve patients’ daily lives.

PATIENT INSIGHTS PROGRAM

Share Your Opinions

The Crinetics Patient Insights Program (PIP) is a forum that gives patients an opportunity to contribute to drug development through important market research. If you are living with carcinoid syndrome stemming from neuroendocrine tumors (NETs), we’d love to hear from you. As a participant, you would play a key role by:

  • Sharing your perspectives via online surveys, virtual calls, and focus groups

  • Taking part in discussions around patient needs, current treatments, and your daily life

  • Contributing to the vital dialog we are committed to continue with people like you

Patients in the PIP are contacted 4-6 times per year to provide opinions and insights regarding their medical condition. PIP members are compensated a fair market value for their time.

Learn more about the Patient Insights Program at Crinetics and sign up here.

PATIENT LEADERSHIP COUNCIL

Your Voice Matters

The Patient Leadership Council (PLC) for carcinoid syndrome due to NETs is also a key way Crinetics practices a patient-focused approach to drug development. This forum gives patients a seat at the table, with opportunities to share their perspectives and first-hand experiences on important topics relevant to their condition, such as:

  • The journey to diagnosis

  • Treatment experiences

  • Educational needs

  • Unmet needs regarding NETs

  • Clinical trial experiences and feedback

Those chosen for the PLC serve for 12 months and attend a monthly video conference call. Members are compensated a fair market value for their time.

Email patientadvocacy@crinetics.com to learn more. 

flyer_lacnets.carcinoidstudy_001.png

This information is for educational purposes only and does not substitute for medical advice or constitute an endorsement by LACNETS. Talk to your medical team about your individual care and treatment. 

bottom of page